Laffer Tengler Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18M | Buy |
71,440
+876
| +1% | +$188K | 2.3% | 10 |
|
|
2026
Q1 | $15.3M | Buy |
70,564
+1,972
| +3% | +$437K | 2.27% | 10 |
|
|
2025
Q4 | $15.7M | Buy |
68,592
+3,526
| +5% | +$803K | 2.38% | 10 |
|
|
2025
Q3 | $15.1M | Buy |
65,066
+2,868
| +5% | +$584K | 2.39% | 9 |
|
|
2025
Q2 | $11.5M | Sell |
62,198
-3,840
| -6% | -$714K | 2.06% | 9 |
|
|
2025
Q1 | $13.8M | Buy |
66,038
+1,657
| +3% | +$322K | 2.95% | 6 |
|
|
2024
Q4 | $11.4M | Buy |
64,381
+7,853
| +14% | +$1.44M | 2.25% | 10 |
|
|
2024
Q3 | $11.2M | Buy |
56,528
+1,432
| +3% | +$267K | 2.26% | 10 |
|
|
2024
Q2 | $9.45M | Buy |
55,096
+11,764
| +27% | +$1.95M | 2.04% | 11 |
|
|
2024
Q1 | $7.89M | Sell |
43,332
-3,153
| -7% | -$543K | 2.04% | 9 |
|
|
2023
Q4 | $7.2M | Buy |
46,485
+2,858
| +7% | +$417K | 1.92% | 12 |
|
|
2023
Q3 | $6.5M | Sell |
43,627
-3,037
| -7% | -$446K | 1.91% | 8 |
|
|
2023
Q2 | $6.29M | Buy |
46,664
+1,869
| +4% | +$274K | 1.67% | 8 |
|
|
2023
Q1 | $7.14M | Buy |
44,795
+1,315
| +3% | +$201K | 1.93% | 3 |
|
|
2022
Q4 | $7.03M | Buy |
43,480
+9,781
| +29% | +$1.5M | 2.02% | 2 |
|
|
2022
Q3 | $4.52M | Buy |
33,699
+1,435
| +4% | +$206K | 1.66% | 6 |
|
|
2022
Q2 | $4.94M | Sell |
32,264
-156
| -0.5% | -$23.8K | 1.74% | 5 |
|
|
2022
Q1 | $5.26M | Sell |
32,420
-2,736
| -8% | -$397K | 1.58% | 7 |
|
|
2021
Q4 | $4.76M | Buy |
35,156
+1,043
| +3% | +$123K | 1.37% | 10 |
|
|
2021
Q3 | $3.68M | Buy |
34,113
+7,568
| +29% | +$865K | 1.06% | 18 |
|
|
2021
Q2 | $2.99M | Buy |
26,545
+3,527
| +15% | +$397K | 1.12% | 30 |
|
|
2021
Q1 | $2.49M | Buy |
23,018
+1,690
| +8% | +$181K | 0.94% | 44 |
|
|
2020
Q4 | $2.25M | Buy |
21,328
+1,679
| +9% | +$161K | 0.95% | 44 |
|
|
2020
Q3 | $1.72M | Sell |
19,649
-1,491
| -7% | -$140K | 0.86% | 51 |
|
|
2020
Q2 | $2.08M | Buy |
21,140
+3,089
| +17% | +$272K | 1.19% | 37 |
|
|
2020
Q1 | $1.38M | Buy |
18,051
+3,095
| +21% | +$264K | 1.07% | 41 |
|
|
2019
Q4 | $1.32M | Buy |
14,956
+7,040
| +89% | +$584K | 0.88% | 47 |
|
|
2019
Q3 | $599K | Sell |
7,916
-146
| -2% | -$10K | 0.51% | 60 |
|
|
2019
Q2 | $586K | Buy |
8,062
+129
| +2% | +$10.1K | 0.5% | 58 |
|
|
2019
Q1 | $639K | Buy |
+7,933
| New | +$649K | 0.17% | 147 |
|
|
2016
Q4 | – | Sell |
-38,166
| Closed | -$2.41M | – | 218 |
|
|
2016
Q3 | $2.41M | Hold |
38,166
| – | – | 0.67% | 46 |
|
|
2016
Q2 | $2.36M | Buy |
+38,166
| New | +$2.33M | 0.67% | 45 |
|
|
2014
Q4 | – | Sell |
-56
| Closed | -$3.23K | – | 219 |
|
|
2014
Q3 | $3.23K | Buy |
+56
| New | +$3.11K | ﹤0.01% | 232 |
|
|
2013
Q3 | – | Sell |
-42,240
| Closed | -$1.75M | – | 256 |
|
|
2013
Q2 | $1.75M | Buy |
+42,240
| New | +$1.85M | 0.34% | 112 |
|
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Laffer Tengler Investments's ABBV Position: Q2 2026 in Review
Laffer Tengler Investments increased its AbbVie (ABBV) stake by 1.2% in Q2 2026, buying an estimated $188K and bringing the position to 71,440 shares worth $18M. The position accounts for 2.3% of the portfolio, ranked #10.
Laffer Tengler Investments first reported a position in ABBV in Q2 2013 and has held it in 34 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Laffer Tengler Investments held 71,440 shares of AbbVie worth $18M as of Q2 2026.
- Laffer Tengler Investments bought 876 AbbVie shares in Q2 2026, an estimated $188K.
- AbbVie made up 2.3% of Laffer Tengler Investments's portfolio in Q2 2026, its #10 holding.
- Laffer Tengler Investments first reported a position in AbbVie in Q2 2013 and has held it in 34 quarters since.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Laffer Tengler Investments's 13F filing for Q2 2026, filed 21 Jul 2026.